Many Wall Street analysts keep boosting their stock price target as the streaming giant's shares have gained around 40 ...

What to expect from Netflix Q2 earnings and a Cover Story deep dive on Trump's war on truth are the features in today's ...

Goldman Sachs Group Inc. (NYSE:GS) shares traded higher Wednesday after the firm reported second-quarter results that beat ...

Ahead of Netflix's Q2 2025 earnings, a recent survey suggests it could raise prices again and the majority of customers would ...

After a strong performance in the second quarter, the regional bank's CEO, Bryan Jordan, talked about the resilience of borrowers in the current economic climate.

The revenue for the cell therapy Carvykti and the EGFR-targeted lung cancer duo Rybrevant-Lazcluze contributed to double digit gains in oncology drug sales.

Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year.Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million.Full-year 2025 ...

Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...

TotalEnergies wobbles between small gains and losses after saying it expects lower oil and gas prices to hurt Q2 earnings, ...

Dutch semiconductor equipment manufacturer ASML (NASDAQ: ASML) warned investors that its sales might not grow at all in 2026, ...

Evercore ISI analyst recommends buying ASML stock even though it no longer sees growth in 2026. Investors should still avoid ASML shares.

In a note to clients, Citi said it expects second-quarter results to come in at the high end of management’s guidance ranges. The firm also highlighted strength in AppLovin’s software platform and ...